Related Experiment Video
Updated: Jun 23, 2026

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
Published on: February 12, 2016
Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke
Giuseppe Licata1, Antonino Tuttolomondo, Domenico Di Raimondo
1Dipartimento Biomedico di Medicina Interna e Specialistica, Università degli Studi di Palermo, Pizza delle Cliniche n.2, 90127 Palermo, Italy.
Insights
Cardio-embolic stroke patients exhibit higher inflammatory biomarkers, leading to worse neurological deficits and larger infarct volumes compared to other stroke types. This suggests increased immuno-inflammatory activation in cardio-embolic strokes.
Area of Science:
- Neuroscience
- Immunology
- Cardiology
Background:
- Limited research exists on the link between inflammatory markers, cardioembolic stroke, and neurological impairment.
- Understanding these relationships is crucial for stroke subtyping and treatment.
Purpose of the Study:
- To compare plasma immuno-inflammatory variables in cardioembolic stroke patients versus other subtypes.
- To investigate the association between inflammatory markers, neurological deficit, and infarct volume in acute ischemic stroke.
Main Methods:
- Evaluated 120 acute ischemic stroke patients and 123 controls.
- Classified stroke subtypes using the TOAST criteria.
- Measured plasma levels of various cytokines (IL-1β, TNF-α, IL-6, IL-10), adhesion molecules (E-selectin, P-selectin, sICAM-1, sVCAM-1), and hemostatic factors (vWF, TPA, PAI-1).
Main Results:
- Cardioembolic ischemic stroke (CEI) patients showed significantly higher TNF-α, IL-6, and IL-1β levels than other subtypes.
- Lacunar stroke patients exhibited significantly lower levels of TNF-α, IL-6, and IL-1β compared to other subtypes.
- The Scandinavian Stroke Scale (SSS) score correlated with stroke subtype, infarct volume in CEI, and certain inflammatory markers.
Conclusions:
- Cardioembolic strokes present with more severe clinical symptoms and larger, more disabling infarcts.
- Elevated immuno-inflammatory activation during the acute phase may explain the severity of cardioembolic strokes.
Abstract:
Few studies have examined the relationship between inflammatory biomarker blood levels, cardioembolic stroke subtype and neurological deficit. So the aim of our study is to evaluate plasma levels of immuno-inflammatory variables in patients with cardio-embolic acute ischaemic stroke compared to other diagnostic subtypes and to evaluate the relationship between immuno-inflammatory variables, acute neurological deficit and brain infarct volume. One hundred twenty patients with acute ischaemic stroke and 123 controls without a diagnosis of acute ischaemic stroke were evaluated. The type of acute ischaemic stroke was classified according to the TOAST classification. We evaluated plasma levels of IL-1beta, TNF-alpha, IL-6 and IL-10, E-selectin, P-selectin, sICAM-1,sVCAM-1, vWF, TPA and PAI-1. Patients with ischaemic stroke classified as cardio-embolic (CEI) showed, compared to other subtypes, significantly higher median plasma levels of TNF-alpha , IL-6 and IL-1beta. Furthermore stroke patients classified as lacunar showed, compared to other subtypes, significantly lower median plasma levels of TNF-alpha, IL-6 and IL-1beta. Multiple linear regression showed a significant association between the Scandinavian Stroke Scale (SSS) score at admission and diagnostic subtype, infarct volume of cardio-embolic strokes and some inflammatory variables. Our findings confirm that cardio-embolic strokes have a worse clinical presentation and produce larger and more disabling strokes than other ischaemic stroke subtypes reporting a possible explanation of higher immuno-inflammatory activation of the acute phase.
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...

